![Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management | Business Wire Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management | Business Wire](https://mms.businesswire.com/media/20230606005187/en/1602634/22/Logo.jpg)
Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management | Business Wire
![University of Newcastle study, funded by Asthma Australia, to examine 'smart inhalers' | Newcastle Herald | Newcastle, NSW University of Newcastle study, funded by Asthma Australia, to examine 'smart inhalers' | Newcastle Herald | Newcastle, NSW](https://www.newcastleherald.com.au/images/transform/v1/crop/frm/3AijacentBN9GedHCvcASxG/84439a65-26e9-4133-98da-0694df8a42c6.jpg/r602_148_1916_884_w1920_h1076_fmax.jpg)
University of Newcastle study, funded by Asthma Australia, to examine 'smart inhalers' | Newcastle Herald | Newcastle, NSW
![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire](https://mms.businesswire.com/media/20200921005170/en/819865/4/TEVA_DH-AirDuo_Inhaler_PhoneL_Conv_LU_W_noBG.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
![BreatheSuite on X: "Up to 90% of #inhalers are are used incorrectly, though inhaler misuse can lead to poor health outcomes and more emergency room visits for people with #asthma and #COPD. BreatheSuite on X: "Up to 90% of #inhalers are are used incorrectly, though inhaler misuse can lead to poor health outcomes and more emergency room visits for people with #asthma and #COPD.](https://pbs.twimg.com/media/FSkV0HCWQAMVMRt.jpg:large)
BreatheSuite on X: "Up to 90% of #inhalers are are used incorrectly, though inhaler misuse can lead to poor health outcomes and more emergency room visits for people with #asthma and #COPD.
![Global Smart Inhaler Technology Market Growth to Accelerate at a CAGR of Almost 43% During 2020-2024 | COVID-19 to Positively Influence Growth | Technavio | Business Wire Global Smart Inhaler Technology Market Growth to Accelerate at a CAGR of Almost 43% During 2020-2024 | COVID-19 to Positively Influence Growth | Technavio | Business Wire](https://mms.businesswire.com/media/20201209005864/en/845566/23/IRTNTR45828.jpg)
Global Smart Inhaler Technology Market Growth to Accelerate at a CAGR of Almost 43% During 2020-2024 | COVID-19 to Positively Influence Growth | Technavio | Business Wire
![Electronic Monitoring Devices to Support Inhalation Technique in Patients with Asthma: a Narrative Review | Current Treatment Options in Allergy Electronic Monitoring Devices to Support Inhalation Technique in Patients with Asthma: a Narrative Review | Current Treatment Options in Allergy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40521-023-00328-7/MediaObjects/40521_2023_328_Fig1_HTML.png)